Resumen
Objective: The objective of this study was to determine whether chronic use of medications with anticholinergic (AC) properties impact older adults' cognitive functioning. Methods: Six years of cognitive test data from two groups of older adults (AC and control) were examined retrospectively (N = 592). Results: Declines over time were found for the AC group on parts A and B of the Trail Making Test. Conclusion: Physicians prescribing ACs to older adult patients should be aware of their potential effects on psychomotor speed and executive functioning. These cognitive effects may lead to impairments in daily functioning resulting in the need to reevaluate patient medications.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 980-984 |
| Número de páginas | 5 |
| Publicación | American Journal of Geriatric Psychiatry |
| Volumen | 14 |
| N.º | 11 |
| DOI | |
| Estado | Published - nov 2006 |
Financiación
| Financiadores | Número del financiador |
|---|---|
| National Institute on Aging | P50AG005144 |
| National Institute on Aging |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Geriatrics and Gerontology
- Psychiatry and Mental health
Huella
Profundice en los temas de investigación de 'Lone-term cognitive impact of anticholinergic medications in older adults'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver